Covenant Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,685
Closed -$443K 175
2024
Q3
$443K Hold
7,685
0.13% 97
2024
Q2
$373K Sell
7,685
-1
-0% -$48 0.11% 119
2024
Q1
$374K Buy
+7,686
New +$375K 0.11% 123
2023
Q4
Sell
-10,655
Closed -$572K 197
2023
Q3
$572K Sell
10,655
-293
-3% -$15.6K 0.21% 83
2023
Q2
$590K Buy
10,948
+293
+3% +$15.8K 0.21% 78
2023
Q1
$580K Buy
+10,655
New +$518K 0.22% 77
2022
Q4
Sell
-16,389
Closed -$623K 189
2022
Q3
$623K Buy
16,389
+3,286
+25% +$146K 0.3% 64
2022
Q2
$656K Sell
13,103
-5,462
-29% -$290K 0.3% 73
2022
Q1
$953K Buy
18,565
+13,741
+285% +$710K 0.38% 49
2021
Q4
$242K Sell
4,824
-15,049
-76% -$744K 0.09% 175
2021
Q3
$958K Hold
19,873
0.38% 52
2021
Q2
$1.05M Hold
19,873
0.4% 48
2021
Q1
$983K Buy
19,873
+15,049
+312% +$723K 0.39% 49
2020
Q4
$234K Sell
4,824
-6,912
-59% -$341K 0.1% 163
2020
Q3
$589K Buy
11,736
+5,494
+88% +$283K 0.29% 78
2020
Q2
$319K Buy
+6,242
New +$303K 0.15% 152

Other funds holding SNY

Covenant Partners's SNY Position: Q4 2024 in Review

Covenant Partners sold out of Sanofi (SNY) in Q4 2024, closing a stake of 7,685 shares — an estimated $443K sold.

Covenant Partners first reported a position in SNY in Q2 2020 and held it in 16 quarters. The position peaked at $1.05M in Q2 2021. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Covenant Partners reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • Covenant Partners sold 7,685 Sanofi shares in Q4 2024, an estimated $443K.
  • Covenant Partners first reported a position in Sanofi in Q2 2020 and held it in 16 quarters.
  • Covenant Partners's Sanofi position peaked at $1.05M in Q2 2021.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Covenant Partners's 13F filing for Q4 2024, filed 14 Feb 2025.